-
Cyanin Chloride in a HaCaT Psoriasis Model
2026-08-24
A 2024 study tested cyanin chloride in chemical radical assays, LPS-stimulated macrophages, and a cytokine-induced HaCaT keratinocyte model of psoriasis. Its central contribution was to connect reduced inflammatory signaling, including STAT3 phosphorylation and CCL20 expression, with recovery of epithelial barrier function measured by TEER, while also highlighting the need to distinguish cyanin chloride from the separately defined compound Cyanidin Chloride.
-
D-Luciferin Potassium Salt for Translational BLI
2026-08-24
D-Luciferin potassium salt connects luciferase biology with practical in vivo bioluminescence imaging, tumor cell tracking, reporter assays, and ATP measurements. This guide translates a glioblastoma nanomotor study into assay decisions, workflow controls, and troubleshooting strategies for reproducible light-based readouts.
-
Protease Inhibitor Cocktail for DFCP1–ATGL Assays
2026-08-23
Protect DFCP1–ATGL complexes, lipid-droplet proteins, and phosphorylation-sensitive readouts during cold extraction with a broad, water-soluble inhibitor system. This workflow explains when EDTA Plus improves assay fidelity, when it can interfere with metal-dependent methods, and how to adapt it for Western blotting, Co-IP, imaging, and purification.
-
EZ Cap™ Firefly Luciferase mRNA Workflow Guide
2026-08-22
Build sensitive reporter experiments around Cap1-capped, polyadenylated mRNA for rapid luciferase expression without relying on nuclear transcription. This guide connects practical delivery, LNP formulation, in vivo imaging, and troubleshooting to help distinguish RNA quality, delivery efficiency, translation, and cell-state effects.
-
DAT PET Tracks Dopaminergic Neuron Maturation
2026-08-22
Goggi et al. showed that longitudinal dopamine transporter PET can monitor the maturation and functional recovery of transplanted human embryonic stem cell-derived dopaminergic neurons in a rat model of Parkinson’s disease. The study’s key contribution is the evidence that DAT imaging correlated with neuronal differentiation more reliably than histological tyrosine hydroxylase expression alone.
-
Proteoform-Specific Drug Interactions in Native Membranes
2026-08-21
Lutomski and colleagues introduce a native mass-spectrometry workflow that releases membrane proteins and signaling complexes directly from retinal disc membranes, preserving links between proteoforms, lipid modifications, and molecular interactions. The study shows that rhodopsin, G proteins, and PDE6 display interaction behaviors that can differ according to proteoform composition, providing a more physiologically grounded framework for evaluating drug selectivity and off-target binding.
-
EZ Cap™ Cy5 Firefly Luciferase mRNA Guide
2026-08-20
A scenario-based guide to using EZ Cap™ Cy5 Firefly Luciferase mRNA (5-moUTP), SKU R1010, for more interpretable mRNA delivery, transfection, and cell-response assays. It explains dual fluorescence–bioluminescence readouts, handling parameters, controls, data interpretation, and practical vendor-selection criteria.
-
Ciprofloxacin Promotes RSL3 Ferroptosis via Zinc
2026-08-20
The reference study identifies a context-dependent role for ciprofloxacin in ferroptosis: unlike its previously reported protection against erastin-induced ferroptosis, ciprofloxacin sensitizes cancer cells to RSL3 through mitochondrial DNA stress and zinc accumulation. The work connects the STING1–CAV2 pathway with mitochondrial Zn2+ handling and reactive oxygen species, providing a mechanistic framework for studying antibiotic–ferroptosis interactions.
-
IWP-L6: Reading Wnt Assays at the Right Level
2026-08-19
IWP-L6 is a potent Porcupine inhibitor for dissecting how Wnt ligand maturation controls developmental, regenerative, and metabolic phenotypes. This article presents an assay-design framework that separates ligand production, pathway reception, and downstream metabolic response.
-
LY294002: PI3K Pathway Workflows
2026-08-19
Build more informative PI3K experiments with LY294002 by linking dose, timing, pathway readouts, apoptosis, autophagy, and angiogenesis phenotypes. This workflow-oriented guide also translates zebrafish vascular findings into practical assay design while highlighting reversibility and off-target considerations.
-
5X Protein Loading Buffer (Reducing) Protocol
2026-08-18
5X Protein Loading Buffer (Reducing) supports consistent protein sample preparation for reducing SDS-PAGE by combining SDS, a sulfhydryl reducing agent, buffer salts, and bromophenol blue. It is intended for denaturing protein molecular weight separation and should not be used when native structure or non-reducing disulfide states must be preserved.
-
ATRX-Deficient Glioma and PDGFR Inhibitor Sensitivity
2026-08-18
The 2022 Cancers study identified ATRX deficiency as a potential biomarker of increased sensitivity to selected receptor tyrosine kinase and PDGFR inhibitors in high-grade glioma cells. Its combination data further suggest that ATRX status may help interpret RTK inhibitor trials and guide studies pairing targeted inhibition with temozolomide.
-
EZ Cap™ Human PTEN mRNA (ψUTP) Workflow
2026-08-17
Build reproducible PTEN-restoration experiments with a Cap 1, pseudouridine-modified reagent designed for efficient mammalian translation. This guide connects practical mRNA handling and nanoparticle screening with cancer research assays focused on PI3K/Akt signaling and trastuzumab resistance.
-
EZ Cap™ Firefly Luciferase mRNA Workflows
2026-08-17
Build faster, cleaner reporter experiments with a Cap1- and poly(A)-optimized mRNA that provides a direct readout of delivery and translation. This guide connects routine luciferase workflows with mechanistic studies of PKM2–TGF-β1 signaling, while emphasizing controls, normalization, and troubleshooting.
-
D-Luciferin Potassium Salt for BLI
2026-08-16
D-Luciferin potassium salt is a water-soluble firefly luciferase substrate for in vivo bioluminescence imaging and in vitro reporter assays. Its defined reaction requirements, product specifications, and workflow limits support reproducible tumor cell tracking and ATP assay development.